Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Mechanobiology of the brain in ageing and Alzheimer's disease

Hall CM, Moeendarbary E, Sheridan GK.

Eur J Neurosci. 2021 Jun;53(12):3851-3878. doi: 10.1111/ejn.14766. Epub 2020 May 18.

Phenolic lipids as unique bioactive compounds: a comprehensive review on their multifunctional activity toward the prevention of Alzheimer's disease

Meshginfar N, Tavakoli H, Dornan K, Hosseinian F.

Crit Rev Food Sci Nutr. 2021;61(8):1394-1403. doi: 10.1080/10408398.2020.1759024. Epub 2020 May 2.

Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways

Lanni C, Masi M, Racchi M, Govoni S.

Mol Psychiatry. 2021 Jan;26(1):280-295. doi: 10.1038/s41380-020-0760-2. Epub 2020 May 7.

Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease

Nanjundaiah S, Chidambaram H, Chandrashekar M, Chinnathambi S.

Cell Mol Neurobiol. 2021 May;41(4):651-668. doi: 10.1007/s10571-020-00883-6. Epub 2020 May 28.

Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis

Plascencia-Villa G, Perry G.

Antioxid Redox Signal. 2021 Mar 10;34(8):591-610. doi: 10.1089/ars.2020.8134. Epub 2020 Jul 17.

Assessing an evidence-based intervention for spouse caregivers of persons with Alzheimer's disease: results of a community implementation of the NYUCI in Israel

Werner P, Clay OJ, Goldstein D, Kermel-Schifmann I, Herz MK, Epstein C, Mittelman MS.

Aging Ment Health. 2021 Sep;25(9):1676-1683. doi: 10.1080/13607863.2020.1774740. Epub 2020 Jun 4.

Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial

Yu F, Salisbury D, Mathiason MA.

J Sport Health Sci. 2021 Jan;10(1):65-72. doi: 10.1016/j.jshs.2020.05.007. Epub 2020 Jun 4.

Modelling neurodegenerative disease using brain organoids

Wray S.

Semin Cell Dev Biol. 2021 Mar;111:60-66. doi: 10.1016/j.semcdb.2020.05.012. Epub 2020 Jun 5.

Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease

Gorantla NV, Chinnathambi S.

Cell Mol Neurobiol. 2021 Aug;41(6):1175-1181. doi: 10.1007/s10571-020-00897-0. Epub 2020 Jun 11.

From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology

Albertini C, Salerno A, de Sena Murteira Pinheiro P, Bolognesi ML.

Med Res Rev. 2021 Sep;41(5):2606-2633. doi: 10.1002/med.21699. Epub 2020 Jun 19.

Insights into lncRNAs in Alzheimer's disease mechanisms

Li D, Zhang J, Li X, Chen Y, Yu F, Liu Q.

RNA Biol. 2021 Jul;18(7):1037-1047. doi: 10.1080/15476286.2020.1788848. Epub 2020 Jul 14.

D-Glucose uptake and clearance in the tauopathy Alzheimer's disease mouse brain detected by on-resonance variable delay multiple pulse MRI

Chen L, Wei Z, Chan KW, Li Y, Suchal K, Bi S, Huang J, Xu X, Wong PC, Lu H, van Zijl PC, Li T, Xu J.

J Cereb Blood Flow Metab. 2021 May;41(5):1013-1025. doi: 10.1177/0271678X20941264. Epub 2020 Jul 16.

Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease

Shevtsova EF, Maltsev AV, Vinogradova DV, Shevtsov PN, Bachurin SO.

Med Res Rev. 2021 Mar;41(2):803-827. doi: 10.1002/med.21715. Epub 2020 Jul 20.

Methylenetetrahydrofolate reductase C667T polymorphism and susceptibility to late-onset Alzheimer's disease in the Italian population

Zuin M, Cervellati C, Trentini A, Roncon L, Guasti P, Zuliani G.

Minerva Med. 2021 Jun;112(3):365-371. doi: 10.23736/S0026-4806.20.06801-9. Epub 2020 Jul 22.

Neurobiological Targets of Apathy Can Guide Treatment Development

Alexopoulos GS.

Am J Geriatr Psychiatry. 2021 Jan;29(1):63-65. doi: 10.1016/j.jagp.2020.06.023. Epub 2020 Jun 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias